1.Leprosy: A Psychological Study: I. leprosy patients in resettlement villages.
Young Pio KIM ; Chang Sung YANG ; K S KIM ; T J WARNBERG
Korean Journal of Dermatology 1981;19(2):135-144
Many factors including social rejection, family problems, loss of educational opportunity, fear, prejudice and ignorance of leprosy compound the inherent psychologicaI stress of leprosy. In light of these problems we have undertaken a study to evaluate the psychological status of several selected groups of leprasy patients. We first studied 340 leprosy patients living in resettlement villages and 304 healthy people living in similar isolated areas. We used a self report symptom inventory, SCL-90 (symptom check list-90), and compared the two-groups. (countinued..)
Humans
;
Leprosy*
;
Prejudice
;
Self Report
;
Social Distance
2.Assessments of myocardial perfusion in human using stress intravenous PESDA myocardial contrast echocardiography and Pulse Inversion Harmonic Imaging: A Comparison study with Tc-99m sestamibi SPECT.
Ki Hwan KWON ; N CHUNG ; J W HA ; S J RIM ; H J KIM ; K J CHANG ; B K LEE ; W B PYUN ; I J KIM ; D K KIM ; D H CHOI ; Y S JANG ; J D LEE ; S Y CHO ; S S KIM
Korean Circulation Journal 2000;30(7):793-802
OBJECTIVE: The object of this study was to assess the accuracy of dipyridamole stress intravenous (IV) myocardial contrast echocardiography (MCE) using pulse inversion harmonic imaging and PESDA in the detection of perfusion defect in the patients with coronary artery disease in comparison with dipyridamole stress Tc-99m sestamibi SPECT. METHODS: Total 46 patients (29 males, mean age 64 years old) were consecutively enrolled. Patients with prior myocardial infarction were excluded. MCE and Tc-99m sestamibi SPECT were performed at the same day during rest and after 0.56 or 0.84mg/Kg dipyridamole infusion. Continuous IV infusion of PESDA (2-5 mL/min) was administered while obtaining triggered (1:1) end-systolic apical 2, 4 chamber and long axis views. Tc-99m sestamibi was injected 3 minutes after dipyridamole. Tc-99m sestamibi SPECT images were obtained one hour later. Coronary angiography was followed within two days in all patients. Tc-99m sestamibi SPECT images were matched to the sixteen segments of left ventricle according to American Society of Echocardiography for segmental comparison. Both images were analyzed visually. Results Using coronary angiography as the standard, MCE showed overall sensitivity of 70.7%, specificity of 95.8%, positive predictive value (PPV) of 87.8% and negative predictive value (NPV) of 88.5% in the detection of coronary atherosclerosis (70% stenosis). Tc-99m sestamibi SPECT showed sensitivity of 75.6%, specificity of 98.9%, PPV of 96.8% and NPV of 90.6%. The overall concordance rate between MCE and Tc-99m sestamibi SPECT for the detection of perfusion defects was 86.9% (Cohen's kappa value 0.63) according to the coronary territory and 86.8% (Cohen's kappa value 0.55) according to segmental analysis. CONCLUSION: Dipyridamole stress IV MCE using pulse inversion harmonic imaging and PESDA is feasible and comparable to Tc-99m sestamibi SPECT in identifying significant coronary stenosis and inducible myocardial perfusion defects in the patients with coronary artery disease. MCE using pulse inversion harmonic imaging seems to be a promising modality for assessing myocardial perfusion in the patients with suspected coronary artery disease.
Axis, Cervical Vertebra
;
Coronary Angiography
;
Coronary Artery Disease
;
Coronary Stenosis
;
Dipyridamole
;
Echocardiography*
;
Heart Ventricles
;
Humans*
;
Male
;
Myocardial Infarction
;
Perfusion*
;
Sensitivity and Specificity
;
Tomography, Emission-Computed, Single-Photon*
3.Treatment of Carcino ma of the Uterine Cervix with High-Dose-Rate Intracavitary Irradiation using Ralstron.
Chang Ok SUH ; Gwi Eon KIM ; John J K LOH
Journal of the Korean Society for Therapeutic Radiology 1990;8(2):231-240
From May 1979 through December 1981 a total of 524 patients with carcinoma of the uterine cervix were treated by radiation therapy with curative intent. Among the 524 patients, 356 were treated with a high-dose-rate (HDR), remote-controlled, afterloading intracavitary irradiation (ICR) system using a cobalt source (Ralstron), and 168 patients received a low-dose-rate (LER) ICR using a radium source. External beam irradiation with a total dose of 40-50 gy to the whole pelvis followed by intracavitary irradiation with a total dose or 30-39 gy in 10-13 fractions to point A was the treatment protocol ICR was given three times a week with a dose of 3 gy per fraction. Five-year actuarial survival rates in the HER-ICR group were 77.6% in stage IB (N=20), 68.2% in stage II (N=182), and 50.9% in stage III (N=148). In LDR-ICR group, 5-year survival rates were 87.5% in stage IB (N=22), 66.3% in stage II (N=91), and 55.4% in stage III (N-52). Survival rates showed a statistically significant difference by stage, but there was no significant difference between the two ICR groups. Late bowel complications after radiotherapy were noted in 3.7% of the HDR-ICR group and 8.4% of the LDR-ICR group. There was no severe complication requiring surgical management. The incidence of bladder complications was 1.4% in the HDR-ICR group and 2.4% in the LDR-ICR group. The application of HDR-ICR was technically simple and easily performed on an outpatient basis without anesthesia, and the patients tolerated it very well. Radiation exposure to personnel was virtually nil in contrast to that of LDR-ICR. Within a given period of time, more patients can be treated with HDR-ICR because of the short treatment time. Therefore, the HDR-ICR system is highly recommended for a cancer center, particularly one with a large number of patients to be treated. In order to tachieve an improved outcome, however, the optimum dose-fractionation schedule of HDR-ICRand optimum combination of intracavitary irradiation with external beam irradiation should be determined through an extensive protocol study with different treatment regimens.
Anesthesia
;
Appointments and Schedules
;
Cervix Uteri*
;
Clinical Protocols
;
Cobalt
;
Female
;
Humans
;
Incidence
;
Outpatients
;
Pelvis
;
Radiotherapy
;
Radium
;
Survival Rate
;
Urinary Bladder
5.Clinical and Therapeutic Aspects of Squamous Cell Carcinoma of Oral Tongue.
Samuel RYU ; Chang Gul LEE ; In Kyu PARK ; Chang Ok SUH ; Gwi Eon KIM ; John J K LOH
Journal of the Korean Society for Therapeutic Radiology 1987;5(2):105-110
Fourty nine patients with squamous cell carcinoma of oral tongue were reviewed retrospectively for the evaluation of clinical manifestation and for the comparison between therapeutic modalites. The gross shape of the tumor was infiltrative in 22, ulcerative in 12, and ulceroinfiltrative type in 10 patients. Direct extension of the tumor was most commonly to the floor of the mouth. The incidence of nodal metastasis generally increased with tumor stage. 55% of the patients showed neck nodal metastasis at the time of diagnosis. Ipsilateral subdigastric node were most commonly involved, followed by submandibular nodes. The 5-year survival rate of patients treated with surgery and radiotherapy was 58.7% in contrast to 21.6% in radiation alone group. Overall 5-year survival rate was 31%. In radiation alone group, half of the patients in stage I, II were locally controlled. But the local control in stage III, IV was much inferior to early lesions. Especially, of 4 patients combined with implantation tecnhnique, 3 were completely controlled. 5-year survival rate of these implanted patients was 50%, 49.4% of patients treated over 7,000 cGy survived 5 years. This was significant in contrast to 6.4% of the group treated below 7,000 cGy. The most common sites of failures were primary sites. In early lesions primary radiotherapy with implantation would be an appropriate treatment in cancer of oral tongue, operation reserved for radiation failure. Operation and adjuvant radiotherapy is recommended in cases of advanced disease.
Carcinoma, Squamous Cell*
;
Diagnosis
;
Humans
;
Incidence
;
Mouth
;
Neck
;
Neoplasm Metastasis
;
Radiotherapy
;
Radiotherapy, Adjuvant
;
Retrospective Studies
;
Survival Rate
;
Tongue*
;
Ulcer
6.Cooperative clinical studies of hyperthermia using a capacitive type heating device GHT-RF8(Greenytherm).
John J K LOH ; Jin Sil SEONG ; Chang Ok SUH ; Gwi Eon KIM ; Sung Sil CHU ; Kyung Ran PAK ; Chang Geol LEE ; Byung Soo KIM ; Soo Gon KIM ; David J SEEL
Yonsei Medical Journal 1989;30(1):72-80
Yonsei Cancer Center developed an RF(Radiofrequency) capacitive type heating device, GHT-RF8(Greenytherm) in cooperation with Green Cross Medical Corp., Korea in 1986 for the first time in Korea. Cooperative clinical studies of hyperthermia for the treatment of cancer using GHT-RF8 were conducted by Yonsei Cancer Center in collaboration with the Presbyterian Medical Center, Chonju, Korea. A total of forty patients with various histologically proven malignant tumors, including superficial (N = 13) and deep-seated tumors (N = 27), were treated with this newly developed heating device in conjunction with radiotherapy (N = 38) or chemotherapy (N = 2) at two different institutes between October 1986 and September 1987. These patients were locally far advanced or recurrent cases and considered to be refractory to conventional cancer treatment modalities. Radiotherapy was given in 200cGy per day, five times a week fractionations with a total tumor dose of 50-60Gy in 5-6 weeks. Within an hour after radiotherapy, the RF capacitive type of hyperthermia was given two times a week for a total of 4-10 treatment sessions and an attempt was made to maintain the tumor temperature at 41-45 degrees C for 30-60 minutes. Of forty patients treated, 14 patients with deep-seated tumors showed complete response and 20 patients showed partial response. The overall response rate was 85% (34 out of 40 patients) and only 6 patients showed no response. Complications from this treatment were mainly burns, superficial first degree burn in 2 cases, second degree in 4 cases and subcutaneous fat necrosis was observed in 2 cases.
Adolescent
;
Adult
;
Aged
;
Equipment Design
;
Female
;
Heating/*instrumentation
;
Human
;
Hyperthermia, Induced/adverse effects/*instrumentation
;
Male
;
Middle Age
;
Neoplasms/radionuclide imaging/therapy
;
Support, Non-U.S. Gov't
;
Tomography, X-Ray Computed
7.The Role of Postoperative Adjuvant Radiation Therapy in the Management of Adenocarcinoma of the Colon: A Review of 21 Patients.
Kyung Ho PARK ; John J K LOH ; Chang Ok SUH ; Dong Won KIM
Journal of the Korean Society for Therapeutic Radiology 1988;6(1):49-54
From March 1970 to December 1984, 21 patients treated initially with curative surgery for adenocarcinoma of the colon, referred to the Department of Radiation Oncology, College of Medicine, Yonsei University, were analyzed retrospectively. Thirteen of 21 patients who were considered to be ah high risk group (i.e, mainly stage B2 or above), received adjuvant postoperative radiation therapy. However, 2 of 13 patients did not complete their courses of radiotherapy as planned because of poor tolerance to radiotherapy or patient's refusal and were excluded from this study. Remaining 8 of 21 patients who did not received postoperative radiotherapy, presented with recurrence at the time of referral and treated with palliative radiotherapy. In 11 patients with postoperative radiotherapy, overall local failure rate was 9% (1/11) and the 5 year acturial survival rate was 55%. Local failure rates by stage were 0(0/4), 14%(1/7) for stage B2+B3, C1+C2+C3 respectively and 0(0/2), 17%(1/6), 0(0/3) for stage C1, B2+C2, B3+C3 respectively.
Adenocarcinoma*
;
Colon*
;
Disulfiram
;
Humans
;
Radiation Oncology
;
Radiotherapy
;
Recurrence
;
Referral and Consultation
;
Retrospective Studies
;
Survival Rate
8.Radiotherapy Results of Nasopharyngeal Carcinoma.
Jong Young LEE ; John J K LOH ; Chang Ok SUH ; Youn Goo LEE ; Won Pyo HONG
Journal of the Korean Society for Therapeutic Radiology 1988;6(1):13-22
This study is the retrospective evaluation of ninety-six patients with biopsy-proven carcinoma of nasopharynx treated with radiotherapy at Yonsei University, College of Medicine, radiation Oncology from January 1971 to December 1985. Patient's age ranged from 15 to 71 years with a median age of 49 years. Fifty-two point five percent of local control and 47.5% of actuarial 5 year survival were achieved with radical radiotherapy. Five year survival rate for Stage I & II, III and IV were 75.0%, 74.6% and 41.4%, respectively. Distant metastasis rate was related with N stage (N1 12.5%, N1 0%, N2 23.5%, N3 32.1%) and histologic type (lymphoepithelioma 41.7%, squamous cell carcinoma 6.5%) but not with T stage. Thirty-one of sixty-seven patient covered adequate radiation field received induction chemotherapy. However induction chemotherapy dose not appear to improve over all survival.
Carcinoma, Squamous Cell
;
Humans
;
Induction Chemotherapy
;
Nasopharynx
;
Neoplasm Metastasis
;
Radiation Oncology
;
Radiotherapy*
;
Retrospective Studies
;
Survival Rate
9.Treatment Planning and Dosimetry of Small Radiation Fields for Stereotactic Radiosurgery.
Sung Sil CHU ; Chang Ok SUH ; John J K LOH ; Sang Sup CHUNG
Journal of the Korean Society for Therapeutic Radiology 1989;7(1):101-112
The treatment planning and dosimetry of small fields for stereotactic radiosurgery with 10 MV x-ray isocentrically mounted linear accelerator is presented. Special consideration in this study was given to the variation of absorbed dose with field size, the central axis percent depth doses and the combined moving beam dose distributon. The collimator scatter correction factors of small fields (1x1~3x3 cm2) were measured with ion chamber at a target chamber distance of 300cm where the projected fields were larger than the polystyrene buildup caps and it was calibrated with the tissue equivalent solid state detectors of small size (TLD, PLD, ESR and semiconductors). The central axis percent depth doses for 1x1 and 3x3 cm2 fields could be derived with the same acuracy by interpolating between measured values for larger fields and calcu1ated zero area data, and it was also calibrated with semiconductor detectors. The agreement between experimental and calculated data was found to be under +/-2% within the fields. The three dimensional dose planning of stereotactic focusing irradiation on small size tumor regions was performed with dose planning computer system (Therac 2300) and was verified with film dosimetry. The more the number of strips and the wider the angle of arc rotation, the larger were the dose delivered on tumor and the less the dose to surrounding the normal tissues. The circular cone, we designed, improves the alignment, minimizes the penumbra of the beam and formats ball shape of treatment area without stellate patterns. These dosimetric techniques can provide adequate physics background for stereotactic radiosurgery with small radiation fields and 10 MV x-ray beam.
Axis, Cervical Vertebra
;
Computer Systems
;
Film Dosimetry
;
Particle Accelerators
;
Polystyrenes
;
Radiosurgery*
;
Semiconductors
10.The Role of Postoperative Adjuvant Radiation Therapy in the Management of Adenocarcinoma of the Colon: A review of 21 Patients.
Kyung Ho PARK ; Dong Won KIM ; John J K LOH ; Chang Ok SUH
Journal of the Korean Society for Therapeutic Radiology 1989;7(1):51-58
From March 1970 to December 1984, treatment results of 21 patients treated initially with curative surgery for adenoarcinoma of the colon and referred to the Department of Radiation Oncology, College of Medicine, Yonsei University, were analyzed retrospectively. Thirteen of 21 patients who were considered to be at high risk (i.e, stage B2 or above), received postoperative adjuvant radiation therapy. However, 2 of 13 patients did not complete their courses of radiotherapy as planned because of poor tolerance to radiotherapy or patient's refusal and were excluded from this study. Remaining 8 of 21 patients who did not receive postoperative radiotherapy, presented with recurrence at the time of referral and treated for palliation. In 11 patients who finished postoperativc radiotherapy, overall local failure rate was 9%(1/11) and the 5 year actuarial survival rate was 55%. Local failure rates by stage were 0(0/4), 14%(1/7) for stage B2+B3, C1+C2+C3 respectively and 0(0/2), 17%(1/6), 0(0/3) for stage C1, B2+C2, B3+C3 respectively.
Adenocarcinoma*
;
Colon*
;
Disulfiram
;
Humans
;
Radiation Oncology
;
Radiotherapy
;
Recurrence
;
Referral and Consultation
;
Retrospective Studies
;
Survival Rate